Our study marked endeavor to delineate the molecular regulatory axis of RAB32 in COPD by employing diverse methods and identifying GPRC5A as a potential interacting molecule with RAB32. This evidence concerns the gene GPRC5A and chronic obstructive pulmonary disease.